Antogen, Inc.
PrivateLast Round
Seed
Jun 9, 2026
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Antogen, Inc. operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Seed round in June 2026.
Antogen, Inc. is a life sciences company that provides immunopeptidomics services and develops tools and diagnostics for immune surveillance.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts, Usage-Based SaaS
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Antogen, Inc. Comparables
Compare Antogen, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MS Bioworks | 77% | |
| Bruker | 74% | |
| Creative Proteomics | 74% |
For institutional investors. Book with your work email.
Antogen, Inc. Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Antogen, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| iGrow Venture Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 9, 2026
Seed round led by iGrow Venture Partners.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- expands_facilitiesOct 22, 2026
Antogen, Inc. expands its physical laboratory facilities with a fully operational laboratory in Oklahoma City on Oct 22nd '26 to scale biopharma services and advance its proprietary diagnostic platform.
For institutional investors. Book with your work email.
Antogen, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Antogen, Inc.'s valuation, stock price, and market status.
Is Antogen, Inc. a public or private company?
Antogen, Inc. is a private company.
What is the current stock price of Antogen, Inc.?
Antogen, Inc. is a private company, so its shares have no public market price. Caplight tracks Antogen, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Antogen, Inc. worth (valuation)?
Valuation information for Antogen, Inc. is not publicly available.
Can I buy Antogen, Inc. stock?
Antogen, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Antogen, Inc.'s last funding round?
Antogen, Inc.'s most recent funding round was Seed on June 9, 2026.
Who are the main investors in Antogen, Inc.?
Key investors in Antogen, Inc. include iGrow Venture Partners.
Will Antogen, Inc. IPO soon?
No public IPO plans have been announced for Antogen, Inc..
How can I track Antogen, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Antogen, Inc.'s shares on secondary markets.